SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Deren-Wesolek, A.
Right arrow Articles by Chojnacka-Wójcik, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deren-Wesolek, A.
Right arrow Articles by Chojnacka-Wójcik, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The novel buspirone analogue, 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl) [butyl]-8 -azaspiro[4.5] decane-7,9 dione, with anxiolytic-like and antidepressant-like effects in rats

Anna Deren-Wesolek

Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Ewa Tatarczynska

Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Ewa Chojnacka-Wójcik

Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

In the conflict drinking test, used as a model to examine anxiolytic-like activity, the novel buspirone analogue 8- [4-[2-(1,2,3,4-tetrahydroisoquinolinyl)]butyl)-8-azaspiro[4.5]decane-7,9-dione (MM199) (0.62-2.5 mg/kg) and buspirone (0.62-5 mg/kg), significantly increased the punished drinking in water-deprived rats, without affecting water consumption or perception of the stimulus. The anticonflict activity of MM199 (1.25 mg/kg) was blocked by (S)-WAY 100135 (20 mg/kg), a 5-hydroxytrypatmine1A (5-HT1A) receptor antagonist. In the forced swimming test, used as a model to examine the antidepressant-like activity, MM199 (5-20 mg/kg) reduced the immobility time, while buspirone (5-20 mg/kg) had no such effect. The reduced immobility induced by MM199 (20 mg/kg) was antagonized by (S)-WAY100135 (10 mg/kg). The above findings suggest that MM199 possesses potent anxiolytic- and antidepressant-like properties which are mediated by activation of 5- HT1A receptors.

Key Words: buspirone • drinking conflict test • 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)]butyl]-8-azaspiro[4.5] decane-7,9-dione • 5-HT1A ligands • forced swimming test • rat

Journal of Psychopharmacology, Vol. 12, No. 4, 380-384 (1998)
DOI: 10.1177/026988119801200409


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement